-
The only way is ethics - December 8, 2023
-
Kanban storage space and time saving continuum - December 8, 2023
-
Kammac leads the way in delivering for Accapi Group - December 6, 2023
-
OpenADR Alliance launches new communications standard to help utilities manage growth in renewable energy sources and EV charging - December 6, 2023
-
LiftEx 2023 brings the lifting industry to Liverpool - December 4, 2023
-
Winners lift their trophies at the biggest ever LEEA Awards - December 4, 2023
-
“THE PANDEMIC IS OVER”: 1st MOVE MARKS 25 YEARS & POSTS PRE-COVID PROFITS - December 4, 2023
-
Bridgestone Brings ENLITEN Technologies to New Ecopia Long-Haul Tyre Range, Enhancing Fuel Efficiency and Cutting Operational Costs for Fleets - November 23, 2023
-
POCKET BOX SCOOPS NORTHERN IRELAND ROAD SAFETY AWARD FOR FLEET TECHNOLOGY INNOVATION - November 22, 2023
-
“Somewhat sustainable”: 85% of pharmaceutical businesses battling for greener future, new supply chain report finds. - November 21, 2023
86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in the next 12 months
Investment in digital agility to improve operational resilience is the area where most work is needed
86% of pharma and biotech companies say they plan to become more digitally agile, according to a new survey of 100 senior pharmaceutical executives.
The survey, conducted by LogiPharma – the world’s leading annual conference covering pharmaceutical and medical device supply chains – asked global heads and directors of supply chain, logistics, procurement and IT how their organisations were upgrading their existing supply chain network to become more digitally agile.
Allowing logistics networks to be flexible and adapt to rapid changes and new innovations, including responding flexibly to geopolitical events and incorporating AI into networks were examples of how pharmaceutical and biotech companies say they will be enhancing their supply chains over the next year.
The number one challenge in building a digital supply chain was gaining visibility on the data and digital maturity roadmap, ensuring organisations can understand how digital transformation can help them recognise and plan for future challenges.
“One of the biggest focuses for our organisation has been utilising supply chain mapping solutions and embedding AI into that solution,” says Peter Stolba, Vice President, Business
Operations and Supply Chain, Trilink Biotechnologies.
“We have recently partnered with an external provider that has effectively mapped our tier one through to tier three suppliers. They have then overlaid AI to manage any risks that take place.
“Should any delays occur at a port, or airport, we are seeing real-time alerts and can respond sooner. Getting supplies has been incredibly difficult over the past two years and knowing immediately how to react to disruptions in the market has been essential.”
Learning from the pandemic
The global pandemic and geopolitical events such as the war in Ukraine have reinforced the need for operational resilience, particularly across global supply chains for vital products like pharmaceuticals.
Those surveyed said most work was needed in data management (22%), to improve the operational resilience, followed by temperature controls (21%) and investing in digital agility (18%).
61% felt that the most important factor for strengthening future supply chains was closer relationships with their suppliers to improve end-to-end visibility.
Peter Stolba adds:
“I think the pandemic has fueled the need for data visibility and the justification for investment into building a more robust digital supply chain. It is important that we leverage the information we have, and make key decisions based on our data points.”